Pioglitazone hydrochloride

Pioglitazone Hydrochloride is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. It is grouped under the following drug class(es): Hypoglycemics and Thiazolidinediones. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Diabiom, Glidipion, Glizofar and Piomed. Its PubChem CID is 60560.

CAS No 112529-15-4
Molecular Formula C19H21ClN2O3S
Molecular Weight 392.9 g/mol
Synonyms 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride

Frequently Asked Questions